RxDoctor Payments DataLook up a doctor →

Idalia Acosta

General Practice · Miami, FLNPI 1285738716

Payments from drug & device makers

$11,360,395in general payments, 2019–2025

Across 3,433 payments — averaging $3309.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$1.9M
  • Boehringer Ingelheim$1M
  • Bayer$1M
  • AstraZeneca$1M
  • Teva Pharmaceuticals USA, Inc.$928K
  • Takeda Pharmaceuticals U.S.A., Inc.$846K
  • plus $4.6M from 33 others
$1,657in research payments, 2019–2025

Across 8 payments — averaging $207.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
  • Gilead$474

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,360,395 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Other general practice in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →